Nestlé to buy Valeant skin-care rights for $1.4 billion

The move by Nestle, which covers Valeant’s Restylane, Perlane and Emervel products, will bolster the Swiss food giant’s newly established dermatology unit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.